tranexamic acid has been researched along with Sepsis in 4 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Sepsis: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the present study, we assessed the impact of inhibition of plasminogen activation by tranexamic acid on the course of staphylococcal sepsis and septic arthritis in mice." | 7.76 | Tranexamic acid, an inhibitor of plasminogen activation, aggravates staphylococcal septic arthritis and sepsis. ( Anäkkälä, N; Jin, T; Jonsson, IM; Kłak, M; Lange, S; Tarkowski, A; Wang, W, 2010) |
| "Tranexamic acid (TnxAc) is an antifibrinolytic agent that is being increasingly used to prevent and control bleeding in conditions such as elective orthopedic surgery, trauma, and post-partum-hemorrhage, which are frequently followed by infection and sepsis." | 5.51 | Hypofibrinolysis induced by tranexamic acid does not influence inflammation and mortality in a polymicrobial sepsis model. ( Annichinno-Bizzacchi, JM; Campos Nogueira, YA; de Lima, F; De Paula, EV; Gomes da Costa, LN; Levy, CE; Orsi, FA, 2019) |
| " In the present study, we assessed the impact of inhibition of plasminogen activation by tranexamic acid on the course of staphylococcal sepsis and septic arthritis in mice." | 3.76 | Tranexamic acid, an inhibitor of plasminogen activation, aggravates staphylococcal septic arthritis and sepsis. ( Anäkkälä, N; Jin, T; Jonsson, IM; Kłak, M; Lange, S; Tarkowski, A; Wang, W, 2010) |
| "Whereas in DIC associated with trauma, since balance between coagulation and fibrinolysis collapses drastically in a short period, both anticoagulantion therapy and antifibrinolytic therapy can be utilized depending on clinical conditions." | 2.53 | [Anti DIC therapy]. ( Sakamoto, Y; Yahata, M, 2016) |
| "Tranexamic acid (TnxAc) is an antifibrinolytic agent that is being increasingly used to prevent and control bleeding in conditions such as elective orthopedic surgery, trauma, and post-partum-hemorrhage, which are frequently followed by infection and sepsis." | 1.51 | Hypofibrinolysis induced by tranexamic acid does not influence inflammation and mortality in a polymicrobial sepsis model. ( Annichinno-Bizzacchi, JM; Campos Nogueira, YA; de Lima, F; De Paula, EV; Gomes da Costa, LN; Levy, CE; Orsi, FA, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campos Nogueira, YA | 1 |
| Gomes da Costa, LN | 1 |
| Levy, CE | 1 |
| Orsi, FA | 1 |
| de Lima, F | 1 |
| Annichinno-Bizzacchi, JM | 1 |
| De Paula, EV | 1 |
| Yahata, M | 1 |
| Sakamoto, Y | 1 |
| Kłak, M | 1 |
| Anäkkälä, N | 1 |
| Wang, W | 1 |
| Lange, S | 1 |
| Jonsson, IM | 1 |
| Tarkowski, A | 1 |
| Jin, T | 1 |
| Dolina, OA | 1 |
| Tiukov, VL | 1 |
| Gur'ianov, VA | 1 |
1 review available for tranexamic acid and Sepsis
| Article | Year |
|---|---|
[Anti DIC therapy].
Topics: Anticoagulants; Antifibrinolytic Agents; Antithrombins; Benzamidines; Disseminated Intravascular Coa | 2016 |
3 other studies available for tranexamic acid and Sepsis
| Article | Year |
|---|---|
Hypofibrinolysis induced by tranexamic acid does not influence inflammation and mortality in a polymicrobial sepsis model.
Topics: Animals; Antifibrinolytic Agents; Biomarkers; Cecum; Coinfection; Cytokines; Disease Models, Animal; | 2019 |
Tranexamic acid, an inhibitor of plasminogen activation, aggravates staphylococcal septic arthritis and sepsis.
Topics: Animals; Antifibrinolytic Agents; Arthritis, Infectious; Enterotoxins; Female; Fibrinolysin; Mice; M | 2010 |
[General anesthesia components during abdominal surgeries in patients with abdominal sepsis].
Topics: Abdomen; Adult; Aged; Anesthesia, General; Antifibrinolytic Agents; Aprotinin; Hemostatics; Humans; | 2005 |